Macleods Recall Blood Pressure Medication Nationwide | JQJO

New Jersey‑based Macleods Pharma USA has recalled thousands of bottles of its blood‑pressure medication, Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets, after the U.S. Food and Drug Administration determined the pills failed dissolution specifications. The recall covers three thousand five hundred twenty‑eight 30‑count bottles from lot 12251163A and two hundred sixteen 90‑count bottles from lot 12251163B, both expiring May thirty‑first, two thousand twenty‑seven. The FDA classified the action as a Class II recall, indicating potential temporary or reversible adverse health consequences. Macleods initiated the recall on October seventh, and the FDA classified it on October twenty‑six. The recall remains ongoing and affects products distributed nationwide. Consumers should check their prescription bottles for the lot number and National Drug Code, NDC 33342‑246‑07 for 30‑count and NDC 33342‑246‑10 for 90‑count bottles.